{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T10:20:46Z","timestamp":1768818046879,"version":"3.49.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP18fk0410016 h0001"],"award-info":[{"award-number":["JP18fk0410016 h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.tube.2022.102242","type":"journal-article","created":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T21:35:05Z","timestamp":1659476105000},"page":"102242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Evaluation of tuberculosis diagnostic biomarkers in immunocompromised hosts based on cytokine levels in QuantiFERON-TB Gold Plus"],"prefix":"10.1016","volume":"136","author":[{"given":"Sahoko","family":"Imoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2265-1950","authenticated-orcid":false,"given":"Maho","family":"Suzukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Motohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maki","family":"Nagase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eri","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazufumi","family":"Takada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shizuka","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahide","family":"Nagase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuji","family":"Teruya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2022.102242_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S2213-2600(19)30418-7","article-title":"WHO global progress report on tuberculosis elimination","volume":"8","author":"Harding","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.tube.2022.102242_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004220","article-title":"The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis","volume":"4","author":"Aabye","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2022.102242_bib3","doi-asserted-by":"crossref","first-page":"e2489","DOI":"10.1371\/journal.pone.0002489","article-title":"The effects of HIV on the sensitivity of a whole blood IFN-gamma release assay in Zambian adults with active tuberculosis","volume":"3","author":"Raby","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2022.102242_bib4","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1183\/13993003.02033-2015","article-title":"First independent evaluation of QuantiFERON-TB Plus performance","volume":"47","author":"Barcellini","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.tube.2022.102242_bib5","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1183\/13993003.01084-2016","article-title":"Preliminary data on precision of QuantiFERON-TB Plus performance","volume":"48","author":"Cirillo","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.tube.2022.102242_bib6","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1183\/13993003.00596-2016","article-title":"Preliminary data on precision of QuantiFERON-TB Plus performance","volume":"48","author":"Gallagher","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.tube.2022.102242_bib7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0008-8749(02)00510-5","article-title":"CD4 is required for the development of a protective granulomatous response to pulmonary tuberculosis","volume":"216","author":"Saunders","year":"2002","journal-title":"Cell Immunol"},{"key":"10.1016\/j.tube.2022.102242_bib8","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1086\/430930","article-title":"Effector functions of heparin-binding hemagglutinin-specific CD8+ T lymphocytes in latent human tuberculosis","volume":"192","author":"Temmerman","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tube.2022.102242_bib9","doi-asserted-by":"crossref","first-page":"e5928","DOI":"10.1371\/journal.pone.0005928","article-title":"Distinct differences in the expansion and phenotype of TB10.4 specific CD8 and CD4 T cells after infection with Mycobacterium tuberculosis","volume":"4","author":"Hoang","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2022.102242_bib10","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1128\/IAI.68.6.3269-3274.2000","article-title":"Identification and characterization of murine cytotoxic T cells that kill Mycobacterium tuberculosis","volume":"68","author":"Silva","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2022.102242_bib11","doi-asserted-by":"crossref","first-page":"7144","DOI":"10.1128\/IAI.68.12.7144-7148.2000","article-title":"Human CD8(+) T cells specific for Mycobacterium tuberculosis secreted antigens in tuberculosis patients and healthy BCG-vaccinated controls in the Gambia","volume":"68","author":"Smith","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2022.102242_bib12","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1128\/IAI.00624-07","article-title":"Impaired expression of perforin and granulysin in CD8+ T cells at the site of infection in human chronic pulmonary tuberculosis","volume":"75","author":"Andersson","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2022.102242_bib13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3904\/kjim.2019.002","article-title":"QuantiFERON-TB Gold PLUS versus QuantiFERON- TB Gold In-Tube test for diagnosing tuberculosis infection","volume":"35","author":"Kim","year":"2020","journal-title":"Korean J Intern Med (Korean Ed)"},{"key":"10.1016\/j.tube.2022.102242_bib14","article-title":"Evaluation of the performance of QuantiFERON\u00ae-TB Gold plus test in active tuberculosis patients","volume":"23","author":"\u00c7avu\u015fo\u011flu","year":"2021","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"10.1016\/j.tube.2022.102242_bib15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jiac.2019.09.009","article-title":"Clinical characteristics of elderly pulmonary tuberculosis in an acute-care general hospital in Tokyo, Japan: a 12-year retrospective study","volume":"26","author":"Hikone","year":"2020","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.tube.2022.102242_bib16","first-page":"22","article-title":"Characteristics of individuals with tuberculosis in an urban, poor population in Osaka City, Japan - a case-control study","volume":"11","author":"Shimouchi","year":"2020","journal-title":"Western Pac Surveill Response J"},{"key":"10.1016\/j.tube.2022.102242_bib17","doi-asserted-by":"crossref","first-page":"690","DOI":"10.5588\/ijtld.16.0764","article-title":"The sensitivity of the QuantiFERON(\u00ae)-TB Gold Plus assay in Zambian adults with active tuberculosis","volume":"21","author":"Telisinghe","year":"2017","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.tube.2022.102242_bib18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/01.MIB.0000438429.38423.62","article-title":"T-cell profiling and the immunodiagnosis of latent tuberculosis infection in patients with inflammatory bowel disease","volume":"20","author":"Arias-Guill\u00e9n","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.tube.2022.102242_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032482","article-title":"Interferon-\u03b3 release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: a systematic review and meta-analysis","volume":"7","author":"Santin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2022.102242_bib20","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jinf.2020.02.009","article-title":"Effect of HIV-infection on QuantiFERON-plus accuracy in patients with active tuberculosis and latent infection","volume":"80","author":"Petruccioli","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.tube.2022.102242_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01870-21","article-title":"Comparison of QuantiFERON-TB Gold in-tube and QuantiFERON-TB gold-plus in the diagnosis of Mycobacterium tuberculosis infections in immunocompromised patients: a real-world study","author":"Xu","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.tube.2022.102242_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7159485","article-title":"Comparison between the interferon \u03b3 release assay-QuantiFERON Gold plus (QFT-Plus)-and tuberculin skin test (TST) in the detection of tuberculosis infection in immunocompromised children","volume":"2020","author":"Primaturia","year":"2020","journal-title":"Pulm Med"},{"key":"10.1016\/j.tube.2022.102242_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152483","article-title":"Combined analysis of IFN-\u03b3, IL-2, IL-5, IL-10, IL-1RA and MCP-1 in QFT supernatant is useful for distinguishing active tuberculosis from latent infection","volume":"11","author":"Suzukawa","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2022.102242_bib24","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jinf.2017.01.016","article-title":"Interleukin-1 receptor antagonist, a biomarker of response to anti-TB treatment in HIV\/TB co-infected patients","volume":"74","author":"Nouhin","year":"2017","journal-title":"J Infect"},{"key":"10.1016\/j.tube.2022.102242_bib25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tube.2018.08.011","article-title":"Cytokine biomarkers for the diagnosis of tuberculosis infection and disease in adults in a low prevalence setting","volume":"114","author":"Clifford","year":"2019","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2022.102242_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163848","article-title":"Cytokine patterns in tuberculosis infection; IL-1ra, IL-2 and IP-10 differentiate borderline QuantiFERON-TB samples from uninfected controls","volume":"11","author":"Wergeland","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2022.102242_bib27","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jinf.2020.02.007","article-title":"Evaluation of cytokine levels using QuantiFERON-TB Gold Plus in patients with active tuberculosis","volume":"80","author":"Suzukawa","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.tube.2022.102242_bib28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jinf.2018.10.017","article-title":"Diagnostic performance of plasma cytokine biosignature combination and MCP-1 as individual biomarkers for differentiating stages Mycobacterium tuberculosis infection","volume":"78","author":"Luo","year":"2019","journal-title":"J Infect"},{"key":"10.1016\/j.tube.2022.102242_bib29","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1128\/IAI.66.5.2319-2322.1998","article-title":"Production of monocyte chemoattractant protein 1 in tuberculosis patients","volume":"66","author":"Lin","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2022.102242_bib30","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev.immunol.26.021607.090326","article-title":"Monocyte-mediated defense against microbial pathogens","volume":"26","author":"Serbina","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.tube.2022.102242_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155840","article-title":"Evaluation of cytokine levels in response to mitogen among HIV-1-infected blood cells and their relationships to the number of T cells","volume":"153","author":"Imoto","year":"2022","journal-title":"Cytokine"},{"key":"10.1016\/j.tube.2022.102242_bib32","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1164\/rccm.201501-0059OC","article-title":"Mycobacteria-specific cytokine responses detect tuberculosis infection and distinguish latent from active tuberculosis","volume":"192","author":"Tebruegge","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.tube.2022.102242_bib33","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.tube.2011.02.006","article-title":"Discriminating between latent and active tuberculosis with multiple biomarker responses","volume":"91","author":"Frahm","year":"2011","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2022.102242_bib34","article-title":"Different patterns of cytokines and chemokines combined with IFN-\u03b3 production reflect Mycobacterium tuberculosis infection and disease","volume":"7","author":"Yu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2022.102242_bib35","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3904\/kjim.2003.18.3.138","article-title":"Changes of plasma interleukin-1 receptor antagonist, interleukin-8 and other serologic markers during chemotherapy in patients with active pulmonary tuberculosis","volume":"18","author":"Lee","year":"2003","journal-title":"Korean J Intern Med (Korean Ed)"},{"key":"10.1016\/j.tube.2022.102242_bib36","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jinf.2017.04.011","article-title":"Mycobacteria-specific cytokine responses as correlates of treatment response in active and latent tuberculosis","volume":"75","author":"Clifford","year":"2017","journal-title":"J Infect"},{"key":"10.1016\/j.tube.2022.102242_bib37","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/j.1469-0691.2009.03104.x","article-title":"Detection of interleukin-2 in addition to interferon-gamma discriminates active tuberculosis patients, latently infected individuals, and controls","volume":"16","author":"Biselli","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.tube.2022.102242_bib38","doi-asserted-by":"crossref","first-page":"e2858","DOI":"10.1371\/journal.pone.0002858","article-title":"Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10","volume":"3","author":"Ruhwald","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2022.102242_bib39","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1186\/s12879-019-4466-5","article-title":"Accumulate evidence for IP-10 in diagnosing pulmonary tuberculosis","volume":"19","author":"Qiu","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.tube.2022.102242_bib40","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.tube.2016.04.009","article-title":"Evaluation of IL-2, IL-10, IL-17 and IP-10 as potent discriminative markers for active tuberculosis among pulmonary tuberculosis suspects","volume":"99","author":"You","year":"2016","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2022.102242_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exger.2013.11.010","article-title":"Immunosenenescence: role of cytomegalovirus","volume":"54","author":"Pawelec","year":"2014","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.tube.2022.102242_bib42","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.cellsig.2005.08.016","article-title":"Differential role of lipid rafts in the functions of CD4+ and CD8+ human T lymphocytes with aging","volume":"18","author":"Larbi","year":"2006","journal-title":"Cell Signal"},{"key":"10.1016\/j.tube.2022.102242_bib43","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/cei.13544","article-title":"Th22 response induced by Mycobacterium tuberculosis strains is closely related to severity of pulmonary lesions and bacillary load in patients with multi-drug-resistant tuberculosis","volume":"203","author":"Imperiale","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.tube.2022.102242_bib44","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/IAI.00709-10","article-title":"Exposure to cigarette smoke inhibits the pulmonary T-cell response to influenza virus and Mycobacterium tuberculosis","volume":"79","author":"Feng","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2022.102242_bib45","first-page":"636","article-title":"T cell profile was altered in pulmonary tuberculosis patients with type 2 diabetes","volume":"24","author":"Wang","year":"2018","journal-title":"Med Sci Mon Int Med J Exp Clin Res"},{"issue":"Suppl","key":"10.1016\/j.tube.2022.102242_bib46","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/S1472-9792(13)70012-X","article-title":"Mycobacterium tuberculosis-specific CD8+ T cell recall in convalescing TB subjects with HIV co-infection","volume":"93","author":"Ongaya","year":"2013","journal-title":"Tuberculosis"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979222000798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979222000798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:47:56Z","timestamp":1761468476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979222000798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":46,"alternative-id":["S1472979222000798"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2022.102242","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of tuberculosis diagnostic biomarkers in immunocompromised hosts based on cytokine levels in QuantiFERON-TB Gold Plus","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2022.102242","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102242"}}